Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Jun 21, 2006; 12(23): 3756-3759
Published online Jun 21, 2006. doi: 10.3748/wjg.v12.i23.3756
Published online Jun 21, 2006. doi: 10.3748/wjg.v12.i23.3756
Factor | P | Odds | 95% confidenceinterval |
ratio | |||
Sex | 0.68 | 1.699 | 0.1-21.0 |
Age | 0.203 | 1.099 | 1.0-1.3 |
Genotype | 0.776 | 1.621 | 0.1-45.5 |
Levels of HCV RNA | 0.114 | 1.006 | 0.99-1.0 |
Hypertension | 0.004 | 246.32 | 5.5-10977.8 |
Diabetes mellitus | 0.211 | 0.122 | 0.1-3.3 |
Abnormal findings in pretreatment optic fundi | 0.904 | 1.192 | 0.1-20.3 |
Platelet | 0.059 | 1.391 | 1.0-1.9 |
Prothrombin time | 0.747 | 0.982 | 0.9-1.1 |
ALT | 0.992 | 1 | 0.98-1.0 |
WBC | 0.964 | 1.027 | 0.4-2.9 |
Response to therapy (SVR or non-SVR) | 0.123 | 0.016 | 0.0-3.1 |
- Citation: Okuse C, Yotsuyanagi H, Nagase Y, Kobayashi Y, Yasuda K, Koike K, Iino S, Suzuki M, Itoh F. Risk factors for retinopathy associated with interferon α-2b and ribavirin combination therapy in patients with chronic hepatitis C. World J Gastroenterol 2006; 12(23): 3756-3759
- URL: https://www.wjgnet.com/1007-9327/full/v12/i23/3756.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i23.3756